Summary: H.R.4158 — 116th Congress (2019-2020)All Information (Except Text)

There is one summary for H.R.4158. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (08/02/2019)

Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act

This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.